Cell Therapy in Heart Failure

Heart Failure Clinics

Volumn 1, Issue 2, 2005, Pages 303-312

  Pfister, Otmar ^a   Jain, Mohit ^b   Liao, Ronglih ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZACITIDINE; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; SCATTER FACTOR; SOMATOMEDIN; STEM CELL FACTOR; VASCULOTROPIN;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; EMBRYONIC STEM CELL; GENE THERAPY; GRAFT REJECTION; GROWTH DISORDER; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLAST; NONHUMAN; REVIEW; SAFETY; SKELETAL MYOBLAST TRANSPLANTATION; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; HEART FAILURE, CONGESTIVE; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIUM; STEM CELL TRANSPLANTATION;

EID: 33751197503     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2005.03.003     Document Type: Review

References (88)

1. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med 336 16 (1997) 1131-1141
2. Braunwald E., and Pfeffer M.A. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol 68 14 (1991) 1D-6D
3. Wencker D., Chandra M., Nguyen K., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111 10 (2003) 1497-1504
4. Chiu R.C., Zibaitis A., and Kao R.L. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60 1 (1995) 12-18
5. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 6829 (2001) 701-705
6. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 11 (2001) 1395-1402
7. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 5391 (1998) 1145-1147
8. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99 7 (2002) 4391-4396
9. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 3 (2001) 407-414
10. Westfall M.V., Pasyk K.A., Yule D.I., et al. Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures. Cell Motil Cytoskeleton 36 1 (1997) 43-54
11. He J.Q., Ma Y., Lee Y., et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 1 (2003) 32-39
12. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16 12 (2002) 1558-1566
13. Yang Y., Min J.Y., Rana J.S., et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 93 3 (2002) 1140-1151
14. Wakitani S., Takaoka K., Hattori T., et al. Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology (Oxford) 42 1 (2003) 162-165
15. Hochedlinger K., and Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 349 3 (2003) 275-286
16. Asakura A., and Rudnicki M.A. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 30 11 (2002) 1339-1345
17. Kotton D.N., Summer R., and Fine A. Lung stem cells: new paradigms. Exp Hematol 32 4 (2004) 340-343
18. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100 1 (2000) 157-168
19. Garry D.J., Meeson A., Elterman J., et al. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci USA 97 10 (2000) 5416-5421
20. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 7 (2001) 829-841
21. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 6 (2003) 763-776
22. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100 21 (2003) 12313-12318
23. Hierlihy A.M., Seale P., Lobe C.G., et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett 530 1-3 (2002) 239-243
24. Martin C.M., Meeson A.P., Robertson S.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265 1 (2004) 262-275
25. Pfister O., Mouquet F., Summer R., et al. Cardiac side-population cells exhibit greater cardiomyogenic potential than bone marrow-derived stem cells. Circulation 110 (2004) III69-III70
26. Mouquet F., Pfister O., Summer R., et al. Bone marrow stem cells contribute to cardiac side population stem cells after myocardial infarction. Circulation 110 (2004) III506-III507
27. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9 (1961) 493-495
28. Chachques J.C., Acar C., Herreros J., et al. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg 77 3 (2004) 1121-1130
29. Eckert P., and Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 26 1 (1991) 77-84
30. Jain M., DerSimonian H., Brenner D.A., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103 14 (2001) 1920-1927
31. Murry C.E., Wiseman R.W., Schwartz S.M., et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 11 (1996) 2512-2523
32. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34 2 (2002) 241-249
33. Ferrari G., Cusella-De Angelis G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 5356 (1998) 1528-1530
34. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 3 (2001) 369-377
35. Mezey E., Chandross K.J., Harta G., et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 5497 (2000) 1779-1782
36. Spangrude G.J., Heimfeld S., and Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 241 4861 (1988) 58-62
37. Osawa M., Nakamura K., Nishi N., et al. In vivo self-renewal of c-Kit + Sca-1 + Lin(low/-) hemopoietic stem cells. J Immunol 156 9 (1996) 3207-3214
38. Goldman J.M., and Horowitz M.M. The international bone marrow transplant registry. Int J Hematol 76 Suppl 1 (2002) 393-397
39. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98 18 (2001) 10344-10349
40. Norol F., Merlet P., Isnard R., et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 102 13 (2003) 4361-4368
41. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 6961 (2003) 968-973
42. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 6983 (2004) 664-668
43. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 6983 (2004) 668-673
44. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 5302 (1997) 964-967
45. Gehling U.M., Ergun S., Schumacher U., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 10 (2000) 3106-3112
46. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 3 (2000) 952-958
47. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 2 (1998) 362-367
48. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 4 (2003) 1340-1346
49. Kalka C., Masuda H., Takahashi T., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 12 (2000) 1198-1202
50. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108 3 (2001) 399-405
51. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 25 (2002) 3017-3024
52. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 3 (1999) 221-228
53. Grant M.B., May W.S., Caballero S., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8 6 (2002) 607-612
54. Urbich C., Heeschen C., Aicher A., et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 20 (2003) 2511-2516
55. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97 7 (2000) 3422-3427
56. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 4 (2001) 430-436
57. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 5 (2001) 634-637
58. Badorff C., Brandes R.P., Popp R., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 7 (2003) 1024-1032
59. Assmus B., Schachinger V., Teupe C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 24 (2002) 3009-3017
60. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 2 (1968) 230-247
61. Tavassoli M., and Crosby W.H. Transplantation of marrow to extramedullary sites. Science 161 836 (1968) 54-56
62. Conget P.A., and Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181 1 (1999) 67-73
63. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
64. Pereira R.F., Halford K.W., O'Hara M.D., et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92 11 (1995) 4857-4861
65. Azizi S.A., Stokes D., Augelli B.J., et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 95 7 (1998) 3908-3913
66. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 5 (1999) 697-705
67. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 1 (2002) 93-98
68. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73 6 (2002) 1919-1925 [discussion: 1926]
69. Hakuno D., Fukuda K., Makino S., et al. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 105 3 (2002) 380-386
70. Xu W., Zhang X., Qian H., et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229 7 (2004) 623-631
71. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 5 (2004) 678-685
72. Weimar I.S., Miranda N., Muller E.J., et al. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34 +). Exp Hematol 26 9 (1998) 885-894
73. Davani S., Marandin A., Mersin N., et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl 1 (2003) II253-II258
74. Oh H., Chi X., Bradfute S.B., et al. Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci 1015 (2004) 182-189
75. Zhou S., Schuetz J.D., Bunting K.D., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7 9 (2001) 1028-1034
76. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20 1 (2002) 11-20
77. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 9 (2004) 911-921
78. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 7 (2003) 1078-1083
79. Hamano K., Nishida M., Hirata K., et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65 9 (2001) 845-847
80. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 9351 (2003) 45-46
81. Strauer B.E., Brehm M., Zeus T., et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr 126 34-35 (2001) 932-938
82. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 18 (2003) 2294-2302
83. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 9429 (2004) 141-148
84. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 15 (2002) 1913-1918
85. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 8 (2004) 1690-1699
86. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 11 Suppl 1 (2004) II213-II218
87. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 9 (2003) 1195-1201
88. Stamm C., Kleine H.D., Westphal B., et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 52 3 (2004) 152-158